FSD Pharma Inc. (HUGE) News

FSD Pharma Inc. (HUGE): $1.68

0.06 (+3.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter HUGE News Items

HUGE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

HUGE News Highlights

  • HUGE's 30 day story count now stands at 5.
  • Over the past 19 days, the trend for HUGE's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • MS are the most mentioned tickers in articles about HUGE.

Latest HUGE News From Around the Web

Below are the latest news stories about FSD Pharma Inc that investors may wish to consider to help them evaluate HUGE as an investment opportunity.

FSD Management and Board Suffers Multiple Court Losses as Shareholder Meeting Approaches

Toronto, Ontario--(Newsfile Corp. - May 12, 2021) - On Monday, May 10, 2021, at the request of Messrs. Anthony Durkacz and Zeeshan Saeed, founding shareholders and members of the group of concerned shareholders (the "Concerned Shareholders") of FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9A) (the "Company" or "FSD"), the Ontario Superior Court of Justice (Commercial List) (the "Court") issued an order appointing Ms. Carol Hansell as independent chair of the Company's shareholders' ...

Yahoo | May 12, 2021

FSD Pharma Announces That ISS Recommends Shareholders Vote for the Company’s Nominees to the Board Using Only the BLUE Proxy

FSD Pharma Inc. (the "Company") today announced that Institutional Shareholder Services Inc. ("ISS"), a leading independent international corporate governance analysis and proxy advisory firm, has recommended that shareholders vote FOR all Company Director Nominees (the "Management Director Nominees") in a contested election for the Board of Directors and FOR the elimination of the dual-class share structure (the "Dual-Class Sunset") at the annual and special meeting of shareholders on May 14, 2021 (the "Meeting").

Yahoo | May 5, 2021

FSD Pharma Announces Appointment of Interim Chief Financial Officer

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") is pleased to announce the appointment of Nathan Coyle, the Company's Corporate Controller as its Interim Chief Financial Officer, following the departure of Donal Carroll, effective immediately.

Yahoo | May 5, 2021

FSD Pharma Issues Important Message to Shareholders and Response to Dissident Circular

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") wishes to alert you to the events that have occurred since the Company filed its Management Information Circular (the "Circular") and the accompanying letter to shareholders related to the Annual & Special Meeting of shareholders scheduled for May 14, 2021, copies of which are available under the Company's SEDAR profile. On April 26, 2021, certain dissident shareholders issued an information circular which included misleading statements and baseless accusations towards the Company's management. In response, the Company issued the following letter to shareholders:

Yahoo | May 3, 2021

FSD Pharma Files Proxy Materials and Sends Letter to Shareholders

FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (the "Company" or "FSD Pharma") announces the filing of its Management Information Circular (the "Circular") and an accompanying letter to shareholders related to the Annual & Special Meeting scheduled for May 14, 2021, copies of which are available under the Company's SEDAR profile.

Yahoo | April 23, 2021

HUGE Stock: FSD Pharma Climbs on Licensing Agreement - CNA Finance

HUGE stock is screaming for the top after the company announced a licensing agreement. This could be a short squeeze.

CNA Finance | March 17, 2021

25 Stocks Moving in Wednesday's Pre-Market Session

Gainers FSD Pharma Inc. (NASDAQ: HUGE) shares rose 50.7% to $3.12 in pre-market trading as the company entered into a license agreement to develop FDA …

Benzinga | March 17, 2021

HUGE Stock: Why Pet Care Play FSD Pharma Is Soaring Today

HUGE stock is on the move Wednesday after FSD Pharma announced a potentially lucrative move in the pet care market. Here's what to know.

InvestorPlace | March 17, 2021

Why Bluebird Bio, Onconova, FSD Pharma, Immatics Are Moving Wednesday

bluebird bio, Inc. (NASDAQ: BLUE ), Onconova Therapeutics, Inc. (NASDAQ: ONTX ), FSD Pharma Inc. (NASDAQ: HUGE ) and Immatics N.V. (NASDAQ: IMTX ) are among the biggest biopharma movers in Wednesday's session. Executive Exodus At Bluebird Bio: Bluebird Bio has seen a couple of high-profile departures recently amid a setback in its gene therapy program for sickle cell disease. The company revealed in a filing that Chief Medical Officer David Davidson has left as of Tuesday. Davidson, however, will continue as a consultant for a period of six months to provide guidance and support for the biopharma's late-stage programs in severe genetic disease, the company said. Earlier this week, Joanne Smith-Farrell, who served as COO and business unit head for oncology at bluebird bio, jumped ship to...

Benzinga | March 17, 2021

FSD Pharma Will stock surge before Earnings results? Stock market Insights & financial analysis

FSD Pharma announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…

Stock Market Daily | March 16, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6108 seconds.